Basit öğe kaydını göster

dc.contributor.authorMelek Bilgin
dc.contributor.authorTuba Yıldırım
dc.contributor.authorMurat Hökelek
dc.date.accessioned09.07.201910:49:13
dc.date.accessioned2019-07-09T21:05:27Z
dc.date.available09.07.201910:49:13
dc.date.available2019-07-09T21:05:27Z
dc.date.issued2013
dc.identifier.issn2146-3123
dc.identifier.urihttps://app.trdizin.gov.tr/publication/paper/detail/TVRZNE1EazVPUT09
dc.identifier.urihttps://hdl.handle.net/20.500.12450/248
dc.description.abstractObjective: Ivermectin and sulphadiazine were tested individually to determine their in vitro effects on Toxoplasma gondii grown in human epidermoid larynx carcinoma (Hep-2) cell culture. Study Design: In-vitro study. Material and Methods: Toxoplasma growth was quantities by an enzyme immunoassay performed directly on the fixed cultures, using a rabbit anti-T. gondii immunoglobulin G as the first antibody and a phosphatase-labeled anti-rabbit immunoglobulin G as the second antibody. For each drug, regres- sion models were used to quantify the relationship between optical density values and antimicrobial agent concentrations in the cultures. Results: The 50% inhibitory concentrations (IC50) of ivermectin and sulphadiazine were found to be 0.2 μg/mL and 7.3 μg/mL after 48 h of exposure, respectively. None of the concentrations tested for each drugs demonstrated toxicity to Hep-2 cells after 72 h of incubation. Conclusion: These results indicate that ivermectin significantly inhibited replication of the tachyzoites of T. gondii RH strain.en_US
dc.description.abstractObjective: Ivermectin and sulphadiazine were tested individually to determine their in vitro effects on Toxoplasma gondii grown in human epidermoid larynx carcinoma (Hep-2) cell culture. Study Design: In-vitro study. Material and Methods: Toxoplasma growth was quantities by an enzyme immunoassay performed directly on the fixed cultures, using a rabbit anti-T. gondii immunoglobulin G as the first antibody and a phosphatase-labeled anti-rabbit immunoglobulin G as the second antibody. For each drug, regres- sion models were used to quantify the relationship between optical density values and antimicrobial agent concentrations in the cultures. Results: The 50% inhibitory concentrations (IC50) of ivermectin and sulphadiazine were found to be 0.2 μg/mL and 7.3 μg/mL after 48 h of exposure, respectively. None of the concentrations tested for each drugs demonstrated toxicity to Hep-2 cells after 72 h of incubation. Conclusion: These results indicate that ivermectin significantly inhibited replication of the tachyzoites of T. gondii RH strain.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCerrahien_US
dc.titleIn vitro effects of ıvermectin and sulphadiazine on toxoplasma gondiien_US
dc.typearticleen_US
dc.relation.journalBalkan Medical Journalen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume30en_US
dc.identifier.issue1en_US
dc.identifier.startpage19en_US
dc.identifier.endpage22en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster